ALB and type 2 diabetes mellitus: CWJI has a protective effect in type 2 diabetes (T2DM) patients with persistent microalbuminuria and normal blood pressure by inhibiting kidney endothelin (ET) synthesis, reducing the level of urinary albumin excretion (UAE), plasma ET concentration, and urinary ET excretion [187].